FDA Inspection
PCI Pharma Services Canada, Inc.PCI Pharma Services Canada, Inc. – FDA Inspection, Feb 28, 2025
Record Details
This FDA Inspection record concerns PCI Pharma Services Canada, Inc., with an inspection on February 28, 2025, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · db327164-ec35-4180-91f4-00ce33bff91e
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1266574
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of PCI Pharma Services Canada, Inc.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| April 17, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 25, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for PCI Pharma Services Canada, Inc.
- FDA Inspection 1091465 - 2019-04-17
- FDA Inspection 852213 - 2013-09-25
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.